官方APP下载:英语全能特训(微信小程序版,支持苹果手机、安卓手机)
创办于2003年
UNSV记不住?那就记中文谐音“忧安思危”吧!
  Slow and Steady Wins the Race!
UNSV英语学习频道 - Slow and steady wins the race!
公众微信服务号
英语全能特训(微信公众服务号)
UNSV英语学习频道淘宝网店
客服短信:18913948480
客服邮箱:web@unsv.com
初级VIP会员
全站英语学习资料下载。
¥98元/12个月

Trump Leaves Hospital after COVID-19 Treatments 从确诊住院到治愈出院,特朗普只用了三天

阅读次数:


VIP会员专享下载:(非VIP会员无权下载!如果想下载,但还不是VIP会员,请点此订购
下载方式:使用鼠标右键(注意是鼠标右键!)点击下面的MP3音频/MP4视频链接,然后选择“另存为…”。
MP3节目录音 MP3节目录音 
文章原文
同步字幕

United States President Donald Trump wrote Monday on Twitter: "I will be leaving the great Walter Reed Medical Center today at 6:30 P.M. Feeling really good! Don't be afraid of Covid. Don't let it dominate your life.' He added, "I feel better than I did 20 years ago!"

Dr. Sean Conley is the president's personal doctor. He said 'though he may not be entirely out of the woods yet, the team and I agree that all our evaluations... support the president's safe return home."

Conley added that privacy "rules and regulations" bar him from sharing information to protect Trump's safety and health.

Trump announced last Friday that he and his wife Melania had tested positive for COVID-19. He has since received several aggressive treatments for the coronavirus during a three-day stay at Walter Reed medical center.

U.S. President Donald Trump pulls off his protective face mask as he poses atop the Truman Balcony of the White House after returning from being hospitalized at Walter Reed Medical Center for coronavirus disease (COVID-19) treatment, in Washington.
U.S. President Donald Trump pulls off his protective face mask as he poses atop the Truman Balcony of the White House after returning from being hospitalized at Walter Reed Medical Center for coronavirus disease (COVID-19) treatment, in Washington.

Oxygen treatment

Dr. Conley first said on Friday that the president "was doing well with only mild symptoms."

Conley later said Trump got 'high fever," or high body temperature, and was given oxygen. He said the president's blood oxygen level was below 94 percent.

The National Institutes of Health's COVID-19 treatment guidelines consider those with blood oxygen level at 94 percent or lower as having moderate to severe illness. The health agency notes that a low level of blood oxygen is common among COVID-19 patients.

President Donald Tump arrives at Walter Reed National Military Medical Center on Friday. Oct. 2, 2020.
President Donald Tump arrives at Walter Reed National Military Medical Center on Friday. Oct. 2, 2020.

Regeneron's antibody treatment

As the president was transported Friday to Walter Reed Medical Center, Conley released a letter saying that the president received an 8-gram dose of experimental antibody treatment from the company Regeneron Pharmaceuticals, Inc. The president also took substances such as: "zinc, vitamin D, famotidine, melatonin and a daily aspirin."

Regeneron's antibody treatment, called REGN-COV2, started its human trial in late June. It combines a "genetically-modified" antibody made by the company and a second antibody from recovered COVID-19 patients.

The treatment is designed to connect the antibodies to the virus that causes COVID-19 and limit its ability to spread in an infected person. This idea has been used in the past to develop drugs to treat other viruses such as HIV, the cause of the disease AIDS.

On September 29, the New York-based company told investors that the treatment appeared to be safe. The company said in a statement that the treatment also reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients.

The treatment, however, has not been studied by independent scientists. And it has not been approved for emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA).

Dr. Sean Conley, physician to President Donald Trump, briefs reporters at Walter Reed National Military Medical Center in Bethesda, Md., Sunday, Oct. 4, 2020.
Dr. Sean Conley, physician to President Donald Trump, briefs reporters at Walter Reed National Military Medical Center in Bethesda, Md., Sunday, Oct. 4, 2020.

Remdesivir

During a news conference Saturday, the president's doctors confirmed that he has started a five-day treatment of the anti-viral drug remdesivir on Friday.

The FDA first approved remdesivir for the treatment of hospitalized patients "with severe COVID-19" in May. The agency expanded the emergency use authorization in August to anyone with COVID-19, regardless of the severity of their disease.

The drug appeared to help patients with moderate COVID-19 to recover faster after a five-day treatment when compared to others with usual care. The result was published in the Journal of the American Medical Association in August.

The National Institutes of Health (NIH) says the drug "works by stopping the virus from spreading in the body." The health agencies warned of possible side effects including damage to liver, low blood pressure and vomiting.

A pharmacist holds a box of dexamethasone tablets at a chemists shop in London on June 16, 2020. - The steroid dexamethasone was shown to be the first drug to significantly reduce the risk of death among severe COVID-19 cases in a trial.
A pharmacist holds a box of dexamethasone tablets at a chemists shop in London on June 16, 2020. - The steroid dexamethasone was shown to be the first drug to significantly reduce the risk of death among severe COVID-19 cases in a trial.

Dexamethasone

On Sunday, Dr. Conley reported that Trump's blood oxygen level on Saturday "dropped down to about 93 percent." He added, 'We watched it and it returned back up.'

The president's doctor also said Trump was given another drug, dexamethasone.

Last June, researchers at the University of Oxford found that dexamethasone cut death rates by around a third among patients with the most severe cases of COVID-19. The drug has been in use since the 1960s to reduce swelling caused by diseases such as arthritis. The researchers said the findings suggest doctors should use the drug immediately as usual treatment for severely sick patients.

The World Health Organization's Director-General Tedros Adhanom Ghebreyesus said at the time, "This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support."

The NIH advises that the drug be used only for hospitalized COVID-19 patients who require oxygen or ventilator support. The guidelines suggest 6 mg a day for up to 10 days or until leaving the hospital.

The agency says the drug has no benefit for patients who do not need oxygen help. And it could limit the body's ability to fight against infection.

The coronavirus, first discovered in Wuhan, China, has now infected more than 35 million people around the world. Johns Hopkins University's Coronavirus Center reported that the disease has also killed more than 1 million people, including about 210,000 in the U.S.

I'm Jonathan Evans.

Hai Do wrote this story for Learning English. Mario Ritter was the editor.

Quiz - Trump's COVID-19 Treatments

Start the Quiz to find out

Start Quiz

Words in This Story

dominate - v. to have control of or power over

out of the woods - phrase, out of danger or difficulties

symptom –n. a change in the body that shows the presence of disease

modified –adj. to have changed some parts of something while not changing all the others

authorization –n. giving legal or officials approval to or for something

mortality –n. the number of deaths that take place in a certain time or place

ventilator –n. (medical) a device, used in a hospital, that helps someone breathe

We want to hear from you. Write to us in the Comments section, and visit our Facebook page.

网友的学习评论(0条):
版权所有©2003-2019 南京通享科技有限公司,保留所有权利。未经书面许可,严禁转载本站内容,违者追究法律责任。 互联网经营ICP证:苏B2-20120186
网站备案:苏公网安备 32010202011039号苏ICP备05000269号-1中国工业和信息化部网站备案查询
广播台